A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults
Clinical trial NCT03824236 · COMPLETED
Trial details
- NCT number
- NCT03824236
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-05
- Primary completion
- 2019-04-30
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.